Health in Estonia

1,140 indicators covering health for Estonia.

IndicatorLatest Year10-yr change Rank
Deaths from cardiovascular diseases by region 8,408 2021 up 1.3% 126th
Total disease burden who 506,552 2021 up 4.3% 150th
Burden of disease who 38,124 2021 up 4.2% 77th
Rate of disease burden from drug use disorders who 676.81 2021 down 31.2% 3rd
Respiratory infections death rate age group 7.35 2022 up 6.3% 74th
Respiratory infection death rate who mdb 32.71 2022 up 326.8% 48th
Prevalence of moderate or severe food insecurity in the population 10.8% 2023 up 13.7% 85th
Male female ratio suicides rates 3.84 2021 down 33.7% 70th
Number of people notified with new episode of TB in a given year 111 2021 down 67.3% 161st
Number of people diagnosed with new episode of pulmonary TB who are 16 2021 down 86.9% 154th
Number of people diagnosed with new episode of pulmonary TB who have 4 2021 down 77.8% 174th
Share of women who are smoking 22 2022 down 16.0% 24th
Comparing the share of men and women who are smoking 33 2022 down 31.1% 69th
Share of men who are smoking 33 2022 down 31.1% 69th
Adults smoking 2007 2018 27.5 2022 down 25.9% 42nd
Cases started on MDR-TB treatment 13 2024 down 72.9% 113th
Prevalence of severe food insecurity in the population 1.1% 2023 up 22.2% 107th
Share healthy diet unaffordable 5.2 2024 down 52.3% 117th
Number of people diagnosed with new episode of pulmonary TB who are 87 2021 down 57.6% 156th
Raised fasting blood glucose (>=7.0 mmol/L) 7.1 2014 up 7.6% 129th
Mean fasting blood glucose (mmol/l) 5.33 2014 up 5.0% 93rd
Raised fasting blood glucose (>= 7.0 mmol/L) 9.3 2014 up 12.0% 69th
Number of people requiring interventions against neglected tropical 3 2024 down 70.0% 150th
Reported number of people requiring interventions against NTDs 3 2024 down 70.0% 163rd
Child deaths from streptococcus by disease 0 2015 down 100.0% 151st
Births attended by skilled health personnel 99.9% 2024 down 0.1% 17th
Percentage of total deaths due to NCDs overall and percentage of 12.91 2021 up 473.7% 128th
Number of new leprosy cases 0 2023 β€” 130th
Pharmacists 6.99 2023 up 6.1% 55th
Health worker density, by type of occupation 10.29 per 10,000 people 2023 up 14.0% 14th
Low birth weight prevalence 4.2% 2020 down 6.7% 151st
Inactivated first-dose polio vaccine (IPV1) immunization coverage 86.0% 2025 down 9.5% 134th
Low birth weight number 0.6 2020 down 14.3% 144th
Number of new hivaids infections who 100 2024 down 50.0% 119th
Reported rabies deaths 0 2023 β€” 61st
Number of current cigarette smokers, estimate 188,000 2030 down 21.7% 129th
Concentrations of fine particulate matter 5.61 2023 down 33.2% 180th
Death rate road traffic injuries 4.5 2019 down 33.8% 162nd
New or unknown treatment history cases: Pulmonary, bacteriologically 72 2023 down 58.6% 164th
Medical doctors not further defined 384 2012 up 308.5% 111th
Life satisfaction vs life expectancy 79.15 2023 up 2.5% 64th
Estimate of current cigarette smoking prevalence 16.9% 2030 down 22.1% 53rd
Estimate of current cigarette smoking prevalence (%) 19.1% 2030 down 20.4% 49th
Tb patients tested positive for hiv 12 2021 down 73.9% 121st
Number of children aged 6-59 months with anaemia 12.45 2019 down 11.8% 162nd
Prevalence of anaemia in children aged 6-59 months 18.0% 2019 down 2.2% 149th
Number of deaths attributed to non-communicable diseases, by type of 3,869 2019 up 7.4% 128th
Hepatitis B surface antigen (HBsAg) prevalence 0.0% 2024 β€” 132nd
Mean hemoglobin level of children aged 6-59 months 120 2019 unchanged 36th
Estimated number of MDR/RR-TB incident cases 30 2024 down 53.1% 121st
Mortality caused by road traffic injury 4.5 per 100,000 population 2019 down 48.9% 163rd
Mortality caused by road traffic injury, female 2.6 per 100,000 female population 2019 down 48.0% 152nd
Mortality caused by road traffic injury, male 6.5 per 100,000 male population 2019 down 50.4% 163rd
Countries with birth registration data that are at least 90 percent 1 2024 unchanged 2nd
Life expectancy - Regions 79.46 Years 2024 up 2.7% 31st
Ipv vaccine coverage 82 2024 down 13.7% 145th
Tb patients living with hiv receiving art 10 2021 down 64.3% 111th
HIV-positive TB patients on ART (antiretroviral therapy) 100.0% 2024 up 26.6% 1st
Hospital beds 41.25 2023 down 15.9% 34th
Treatment success rate for patients treated for MDR-TB 88.0% 2022 up 15.8% 26th